NCCN Guidelines

Guidelines

• NCCN Guidelines Version 3.2025

Evidence Blocks

• NCCN Guidelines with Evidence Blocks Version 6.2024

Frameworks

• Basic Framework (English) Version 1.2024

• Core Framework (English) Version 1.2024

• Enhanced Framework (English) Version 1.2024

Guidelines for Patients

• Invasive Breast Cancer-English Version 2024

• Metastatic Breast Cancer-English Version 2024

• Ductal Carcinoma In Situ-English Version 2024

• Inflammatory Breast Cancer-English Version 2023

• Ductal Carcinoma In Situ-Spanish Version 2023

• Metastatic Breast Cancer-Spanish Version 2023

• Invasive Breast Cancer-Spanish Version 2023

• Inflammatory Breast Cancer-Spanish Version 2023

Educational Events and Programs

Calendar of Events

Continuing Education

• Recorded Presentation from the NCCN Pharmacy Updates: Novel Therapies for Treating ESR1 and RET-Fusion Mutations in Breast Cancer

• Archived NCCN Tumor Boards: Treatment Selection Strategies and Barriers to Clinical Care in Metastatic Breast Cancer

• Biomarker Testing and Interpretation after Breast Cancer Diagnosis

• Neoadjuvant/Adjuvant Treatment of Early-Stage Breast Cancer with SABCS Updates

• Updates to Radiation Therapy for Invasive Breast Cancer with SABCS Updates

• Surgical Management of DCIS and Invasive Breast Cancer with SABCS Updates

• Management of CNS Metastases in Patients with Breast Cancer

• Advances in the Management of Metastatic Breast Cancer with SABCS Updates

• Inequities in Clinical Outcomes in Breast Cancer: Do Biologic Differences Based on Ancestry/Racial Identity Play a Role?

• Survivorship Care for Patients Living with Metastatic Breast Cancer

International

Disclosures

• Disclosure Policy

• Panel Member Disclosures

• Panel Member Disclosures by Meeting Date

• End User License Agreement